Inspection Record

Nanjing Cuccess Pharmaceutical Co., Ltd — FDA 483 Findings

US FDAInspected 2025-03-21Published 2026-07-10 3 findingsEquipment and facilityStability and storage

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

Routine checking of automatic and electronic equipment is not performed according to a written program designed to assure proper performance.

2Equipment and facility

Equipment and utensils are not cleaned, maintained and sanitized at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.

3Stability and storage

The written stability testing program is not followed.

About this record

Extracted automatically from the document US FDA published on 2026-07-10. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Nanjing Cuccess Pharmaceutical Co., Ltd company profile — full history US FDA documents, 2026 Go to Findings search